Startseite

In 2021, FAU was awarded almost a quarter of a billion euros in third-party funding. With an increase of more than eight percent, this means FAU, which is the largest university in Northern Bavaria, has once again increased the volume of third-party funding it receives.

The Erlangen location of the Bavarian Center for Cancer Research (BZKF) is providing start-up funding worth a total of 110,000 euros to three research projects at Universitätsklinikum Erlangen. The aim of the projects is to conduct fundamental research into new therapeutic approaches for treating cancer.

LOW-HIIT concept of the Erlangen Hector Center has been proven to help several health conditions such as chronic diseases, obesity or a fatty liver. LOW-HIIT is also a safe and feasible method of training for patients with advanced cancer.